The research team, led by Dr. Kristyn Pocock, assistant professor of neurology at Wake Forest University School of Medicine, drew on a medical record database covering women treated between 2017 and 2024 at clinics affiliated with Stanford Medical Center. The analysis included 687 women in total: 347 diagnosed with macromastia and 340 without the condition. To isolate the effect of enlarged breast tissue itself, the investigators statistically adjusted for several potential confounders, including age, body mass index, depression and anxiety. These factors matter because each is independently associated with headache disorders, musculoskeletal pain and sleep-disordered breathing, so failing to control for them could have exaggerated the apparent link between breast size and the studied outcomes.

After those adjustments, the associations remained striking. Women with macromastia were roughly 40 percent more likely to have chronic migraine, defined as experiencing headache on 15 or more days per month for at least three months. They were about twice as likely to report neck pain, approximately 50 percent more likely to have obstructive sleep apnea, and more than twice as likely to be diagnosed with cervical radiculopathy compared with women without the condition. The magnitude of these increases is notable for conditions that each impose substantial individual burdens on quality of life, work productivity and health care utilization, and the fact that all four clustered together in the same patient group strengthens the case that the pattern is not a statistical accident.

Many people think of enlarged breast tissue primarily as a cosmetic issue, but our findings suggest it may be associated with a broader range of women’s health concerns, including chronic migraine, neck pain and sleep-related breathing disorders, Pocock said. By better understanding these connections, we can help ensure women receive more comprehensive evaluations and care for symptoms that may affect their daily lives. Her comments reflect a recurring theme in macromastia research: patients frequently bring complaints of headache, neck and back pain, and shoulder discomfort to their physicians, and many seek breast reduction surgery specifically to relieve these symptoms rather than for aesthetic reasons.

The symptom profile described by patients has long been recognized in clinical practice, and some insurers already acknowledge headaches as a qualifying symptom when evaluating coverage requests for reduction mammaplasty. However, the researchers point out that relatively little rigorous epidemiological work has examined how enlarged breast tissue relates to specific headache disorders, rather than to undifferentiated head pain, or to neurological conditions affecting the cervical spine. By using structured diagnostic codes from electronic health records, the new study moves beyond anecdote and provides quantified associations for individually named conditions, including the distinction between episodic and chronic migraine, a difference with major implications for treatment planning and prognosis.

One of the more provocative secondary findings concerned breast reduction surgery. When the investigators examined which factors were associated with undergoing reduction procedures among the women with macromastia, neck pain emerged as the only condition linked to a significantly greater likelihood of surgery. This suggests that the musculoskeletal consequences of carrying excess breast tissue, rather than headaches or sleep apnea, may weigh most heavily in decisions by patients and clinicians to pursue operative treatment. It also hints that the full spectrum of associated conditions may be under-recognized during preoperative evaluation, and that some women could experience broader symptomatic benefits from surgery than current documentation captures.

From a mechanistic standpoint, several plausible biological pathways could explain the observed associations. Excess anterior chest wall mass alters head and neck posture, shifting the center of gravity forward and increasing sustained contraction of cervical paraspinal and trapezius muscles, a known trigger for cervicogenic pain and potentially for migraine exacerbation through heightened nociceptive input to the trigeminocervical complex. Chronic muscular strain and poor sleep posture may also worsen sleep quality, while increased soft tissue and altered thoracic mechanics could contribute to airway compromise during sleep, raising the likelihood of obstructive sleep apnea. Nerve root compression in the neck, meanwhile, could arise from compensatory spinal loading and degenerative changes accelerated by altered posture. None of these pathways has yet been definitively demonstrated, and the authors are careful to frame their results as associative rather than causal.

Indeed, the study design carries important limitations that shape how the findings should be interpreted. Because the research was a cross-sectional review of existing medical records, it captures associations at a single point in time and cannot establish whether macromastia causes migraine, neck pain or sleep apnea, whether these conditions share common risk factors, or whether reverse causation plays a role. The cohort was drawn from headache and neurology clinics, a setting that may overrepresent patients with severe symptoms and limit generalizability to the broader population of women with macromastia. Residual confounding is also possible despite the statistical adjustments, particularly for factors such as physical activity, occupational demands and detailed measures of body fat distribution that may not be fully captured in routine clinical records.

Additional research is needed to determine the mechanisms through which macromastia influences migraine, neck pain or sleep apnea, the researchers note, and longitudinal studies could clarify whether treating macromastia, surgically or otherwise, leads to measurable improvement in these conditions. If such benefits are confirmed, macromastia treatment could enter the conversation around comprehensive management of chronic headache and sleep disorders in women, and insurers could be prompted to re-evaluate the criteria used to authorize reduction surgery. These findings raise important questions about how enlarged breast tissue may contribute to painful symptoms for women, Pocock said. More research is needed to determine whether treating macromastia could help certain women find relief and enhance quality of life.

For now, the study offers clinicians a concrete evidence base for taking patient-reported symptoms of headache, neck pain and sleep disturbance seriously when evaluating women with enlarged breast tissue, and it offers patients validation that their complaints may reflect a recognizable clinical pattern rather than isolated grievances. Published in Headache: The Journal of Head and Face Pain, the analysis adds macromastia to the growing list of physical factors that neurologists and sleep specialists may need to consider when assessing women with chronic migraine, cervical nerve disorders or sleep-disordered breathing. As the authors emphasize, the next step is to determine whether relieving the mechanical burden of enlarged breast tissue translates into durable relief from the neurological and sleep conditions that so often accompany it.

Subject of Research: Associations between macromastia in women and chronic migraine, neck pain, cervical radiculopathy and obstructive sleep apnea

Article Title: Women with enlarged breast tissue more likely to experience chronic migraine, neck pain and sleep apnea, study finds

Article References: Women with enlarged breast tissue more likely to experience chronic migraine, neck pain and sleep apnea, study finds. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: macromastia, chronic migraine, neck pain, obstructive sleep apnea, cervical radiculopathy, breast reduction surgery, Wake Forest University School of Medicine, women's health, neurology, electronic health records, Headache journal, Women